Medtronic Launches Award-Winning Neuro Oncology Surgical Imaging System in the United States

PoleStar® N30 Surgical MRI for Neurosurgery Designed to Help Optimize Tumor Resection Procedures

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.

Providing real-time imaging in the operating room (OR), the PoleStar Surgical MRI provides surgeons with targeting and navigational accuracy despite the anatomy movement that may occur during a surgical procedure. With intra-operative imaging information, neurosurgeons gain more confidence to achieve maximum tumor resection, while avoiding critical areas of the brain. Use of the PoleStar system may also reduce the need for revision surgeries and the length of stay at the hospital for the patient.

“This is the next generation of intra-operative MRI providing flexibility, enhanced ergonomics and confidence in the achievement of surgical goals,” said Jim Cloar, vice president and general manager of the Navigation division, part of the Surgical Technologies business at Medtronic. “With its unique compact design, the PoleStar Surgical MRI system enables neurosurgeons to benefit from intra-operative MR imaging without the compromises inherent in other systems, such as extensive renovation of the operating room or restrictions upon the surgeons' choice of instruments.”

Dr. Moshe Hadani, Chairman of Neurosurgery, Sheba Medical Center in Israel was a frequent user of the previous model of the PoleStar Surgical MRI. “Recently we installed the PoleStar N30 System. We have found the new PoleStar to have great improvements in ergonomics. The scanner is smaller, easier to handle and it fits better into the OR environment. Using the PoleStar, I have great confidence in the extent of tumor resection prior to closing.”

More than 50 PoleStar systems have been installed in ORs worldwide since 2001. The launch of the PoleStar N30 is the culmination of six years of research and development by Medtronic scientists and engineers working with surgeon customers from leading hospitals and clinics.

The PoleStar N30 system received the Chicago Athenaeum Museum of Architecture and Design 2009 Good Design Award – the world’s oldest and most prestigious award for global design excellence.

About Medtronic

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.


Medtronic, Inc.
Jeff Warren, 763-505-2696
Investor Relations
Chuck Grothaus, 763-505-2614
Public Relations

KEYWORDS:   United States  North America  Minnesota  Middle East  Israel

INDUSTRY KEYWORDS:   Surgery  Technology  Hardware  Audio/Video  Health  Hospitals  Medical Devices  Oncology  FDA



Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.